SS

Subuhi Sherwani

University of Ha'il, Mohammad Ali Jauhar University, Cardiff University

Research areas: Medicine · Rheumatology · Advanced Glycation End Products research · Nanoparticles: synthesis and applications · Systemic Lupus Erythematosus Research

ORCID iD 0000-0002-0631-708X

Employment

Education

Education history is unavailable.

Projects & Funding

  • Reactivation & Rebuilding of Medical and Diagnostic Research Center, University of Ha’il The Research, Development and Innovation Authority (RDIA)
    2024 - Present
  • Role of estrogenized insulin in the etiopathogenesis of estrogen related cancers’ The Deanship of Scientific Research, University of Hail
    2022 - Present
  • Development of diagnostic assay: highly sensitive and selective nanoarray sensor for breath analysis in COVID-19 infection’ The Deanship of Scientific Research, University of Hail
    2022 - 2024
  • Synthesis of nanoparticles from natural metabolites for the assessment of anti-biofilm activity in multidrug resistant bacteria’ Deanship of Scientific Research, University of Hail
    2021 - 2024
  • Multi-center analysis of hematological characteristics of Covid-19 patients in Saudi Arabia Deanship of Scientific Research, University of Hail,
    2021 - 2024
  • Immune-Serological Evaluation of S1-RBD Neutralising antibodies in general population and patients with chronic diseases in Hail Deanship of Scientific Research, University of Ha'il
    2020 - 2021
  • Natural products and their derivatives: Potential function as anti-glycation and anti-oxidant and role in immune imbalance in age-related disorders Deanship of Scientific Research, University of Hail
    2020 - Present
  • HSA based Cancer Cell Membrane-Coated Nanoparticles for Advanced Delivery of Cisplatin [A multimode drug delivery system] Research Development Office, Ministry of Education KSA
    2019 - Present
  • The role of 16 α-hydroxyestrone (16 α-OHE1) in the etiopathogenesis of estrogen related cancers The Deanship of Scientific Research, King Khalid University
    2018 - Present
  • Novel Combinational Anti-Cancer Therapeutics: Synergistic Effect of Carbamoyl Methyl Amide (CMAs) Derivatives and γδ T Cells on the Cytotoxicity of Cancer Cells Deanship of Research, University of Hail

Publications (45)